SeekingAlpha · Nov 5, 2026
Balchem: Solid Q3 Performance Support Buy Rating
Balchem Corp. delivered a strong Q3, with a record net income of $46.7M and 8.6% revenue growth. Read why BCPC stock is a buy.
NASDAQ · BCPC
Balchem Corporation
Basic Materials · Chemicals - Specialty
$173.14
Up+$0.79 (+0.46%)
Updated Nov 15, 2026, 7:33 AM
SID Score
5.7/10
Composite research score
Smart Money
59/100
Neutral
- Market cap
- 5.09B
- P/E ratio
- 34.44
- Dividend yield
- 0.50%
- 52-week range
- $147.18 – $186.15
- Volume
- 144.01K
- Avg. volume
- 172.4K
Price performance · BCPC
BCPC price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
BCPC closed at $173.14 after 20 trading sessions, up 1.60% for the selected period.
- Last close
- $173.14
- Period change
- +1.60%
- Period low
- $166.30
- Period high
- $182.58
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $172.69 | $174.97 | $172.24 | $173.14 | 144.01K |
| Nov 12, 2026 | $174.58 | $175.50 | $172.035 | $172.35 | 178.68K |
| Nov 11, 2026 | $174.12 | $174.12 | $170.78 | $173.30 | 199.52K |
| Nov 10, 2026 | $175.15 | $178.29 | $173.42 | $173.54 | 197.07K |
| Nov 9, 2026 | $175.88 | $178.50 | $173.96 | $175.99 | 280.14K |
| Nov 6, 2026 | $177.19 | $177.97 | $174.01 | $174.43 | 425.48K |
| Nov 5, 2026 | $183.90 | $186.15 | $178.31 | $179.71 | 543.22K |
| Nov 4, 2026 | $179.13 | $183.32 | $178.93 | $182.58 | 452.54K |
| Nov 3, 2026 | $174.60 | $178.24 | $172.555 | $175.51 | 322.48K |
| Nov 2, 2026 | $172.35 | $175.085 | $171.02 | $174.60 | 168.58K |
| Oct 30, 2026 | $172.89 | $172.89 | $169.73 | $169.98 | 249.29K |
| Oct 29, 2026 | $168.32 | $170.62 | $166.5301 | $170.40 | 196.2K |
| Oct 28, 2026 | $169.52 | $170.40 | $165.77 | $166.30 | 168.34K |
| Oct 27, 2026 | $170.24 | $170.81 | $168.20 | $168.70 | 224.75K |
| Oct 26, 2026 | $178.12 | $178.57 | $169.64 | $170.62 | 331.09K |
| Oct 23, 2026 | $175.83 | $177.45 | $173.085 | $177.00 | 717.79K |
| Oct 22, 2026 | $170.68 | $173.43 | $170.54 | $173.23 | 493.94K |
| Oct 21, 2026 | $171.11 | $172.74 | $170.25 | $170.78 | 452.86K |
| Oct 20, 2026 | $170.68 | $172.585 | $169.7152 | $171.62 | 336.34K |
| Oct 19, 2026 | $170.61 | $171.11 | $169.98 | $170.42 | 363.5K |
Latest BCPC news
The latest Smart Investors Daily articles mentioning BCPC.
Stock researchCompany · Overview
Company
Market Activity
Research & News
BCPC research
Overview
Company profile and research snapshot.
Company profile
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $175.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 3, 2026 | HC Wainwright & Co. | Buy | — |
| May 4, 2026 | HC Wainwright & Co. | Buy | — |
| Feb 24, 2026 | HC Wainwright & Co. | Buy | — |
| Dec 5, 2025 | Rothschild & Co | Neutral | — |
| Oct 22, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
ChartMill · Nov 4, 2026
Balchem (NASDAQ:BCPC) Looks Like a Quality Investment, but Its Valuation Is Full
Balchem fits quality-investing criteria with high ROIC, low debt/FCF, and strong cash-backed profits, though its premium valuation is a key risk.
Yahoo · Oct 28, 2026
Balchem Corporation to Participate in Baird’s Global Industrial Conference on November 11, 2026
MONTVALE, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in Baird’s Global Industrial Conference on November 11, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corporation Balche
SeekingAlpha · Oct 26, 2026
Balchem Corporation 2026 Q3 - Results - Earnings Call Presentation
2026-10-26. The following slide deck was published by Balchem Corporation in conjunction with their 2026 Q3 earnings call.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
